Skeletal muscle lymphocytic vasculitis in systemic lupus erythematosus: relation to disease activity

Abstract

Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was compared with SLE disease activity scored using the British Isles Lupus Assessment Group Index (BILAG). Ten of the 22 patients with active disease showed evidence of LV compared with none of the four patients with inactive disease. In the patient group with LV, significantly higher ESR and urine neopterin values were found with P = 0.002 and P = 0.02, respectively compared with patients without LV. Features of vasculitis (as defined by BILAG) were also significantly more common in these patients (P = 0.005). None of the other parameters, including creatine kinase, were significantly different between the two patient subgroups. Thus, LV in needle quadriceps muscle biopsy specimens is a further valuable marker of disease activity in patients with SLE and might provide histological evidence of a systemic vasculitic process in a group of patients with diverse clinical manifestations.

Keywords

muscle biopsy lymphocytic vasculitis BILAG

Get full access to this article

View all access options for this article.

References

Lim KL et al. Muscle abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis 1994; 53: 178-182.

Lowe J. , Stevens A. , Powell R. Detection of subclinical inflammatory involvement of muscle in connective tissue disorders by needle biopsy. J Pathol 1986; 148: 72A (abstract 30).

Hopkinson N. , Doherty M. , Powell R. Laboratory parameters associated with lymphocytic vasculitis in patients with systemic lupus and mixed connective tissue disease . Electroencephalogr Clin Neurophysiol 1991 ; 78: 4(abstract).

Symmons Dpm et al. Development and assessment of a computerised index of clinical disease activity in systemic lupus erythematosus. Quart J Med 1988; 258: 927-937.

Tan E. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

Bennett R. The fibromyalgia syndrome: myofascial pain and the chronic fatigue syndrome . In: Kelley W et al. (eds). Textbook of Rheumatology, 4th edn. Philadelphia: W.B. Saunders, 1993 : 471-483.

Lim KL et al. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate and plasma C3, C4 and C3 degradation products. Ann Rheum Dis 1993; 52: 429-435.

Edwards R. et al. Modern methods of diagnosis of muscle disease. J R Coll Physicians Lond 1986; 20: 49-55.

Bedell S. , Bush B. Erythrocyte sedimentation rate: from folklore to facts. Am J Med 1985; 78: 1001-1009.

10.

Wachter H. et al. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141.

11.

DeVere R. , Bradley WG Polymyositis: its presentation, morbidity and mortality. Brain 1975; 98: 637-666.

12.

Wees SJ , Sunwoo IN , Oh SJ Sural nerve biopsy in systemic necrotising vasculitis. Am J Med 1981; 71: 525-532.

13.

Rappaport WD et al. Clinical utilisation and complications of sural nerve biopsy. Am J Surg 1993; 166: 252-256.

14.

Dahl E. , Baggenstoss A. , DeWeerd J. Testicular lesions of periarteritis nodosa with special reference to diagnosis . Am J Med 1960; 28: 222-228.

15.

DeShazo RD et al. Systemic vasculitis with coexistent large and small vessel involvement. A classification dilemma. JAMA 1977; 238: 1940-1942.

16.

Tribe CR , Scott DG , Bacon PA Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol 1981; 34: 843-850.

17.

Dahlberg PJ , Lockhart JM , Overholt EL Diagnostic studies for systemic necrotising vasculitis. Sensitivity, specificity and predictive value in patients with multisystem disease. Arch Intern Med 1989; 149: 161-165.

18.

Bick R. Vascular disorders associated with thrombo-haemorrhagic phenomena. Semin Thromb Hemostas 1979; 5: 167-183.

19.

Dvorak H. et al. Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest 1974; 31: 111-130.

20.

Till G. , Ward P. Two distinct chemotactic factor inactivators in human serum. J Immunol 1975; 114: 843-847.

21.

Andrews B. et al. Circulating and tissue immune complexes in cutaneous vasculitis . J Clin Lab Immunol 1979; 1: 311-320.

22.

Luger T. , Smolen J. The role of lymphokines in the pathogenesis of systemic lupus erythematosus . In: Smolen J , Zielinski C (eds). Systemic Lupus Erythematosus. Clinical and Experimental Aspects. Berlin: Springer-Verlag, 1987: 145-167.

23.

Pallis M. et al. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 667-671.

24.

Pober J. Cytokine mediated activation of vascular endothelium. Am J Pathol 1988; 133: 426-433.